HomeHow Did The BioSig Technologies (BSGM) Stock Surged In The Pre-Market Session,...

How Did The BioSig Technologies (BSGM) Stock Surged In The Pre-Market Session, Jumping 16%?

At the time of our most recent check, BioSig Technologies Inc. (NASDAQ: BSGM) shares were up 15.93% to trade at $0.5590 in pre-market. We may then point to recent events to offer a fuller picture of the firm as the BSGM stock increased in the absence of recent news.

How have recent events been at BSGM?

Recently, Cleveland Clinic Foundation (CCF) and BioSig Technologies (BSGM) entered into a research partnership to explore new clinical uses for the intracardiac signals collected by the PURE EP System. According to the conditions of the research agreement, Cleveland Clinic will carry out a physician-initiated scientific study into how well PURE EP can handle typical signal processing and signal usage expansion issues during electrophysiology ablation operations, among other things.

Top 5 Undervalued Stocks To Own In 2023

Microchip Maker Releases "World's Most Powerful Data Center CPU". It could allow the company who manufactures it to lead the industry as the global microchip shortage continues into the coming year. We've put together a free research report that explains all the details. Not only will you find out why analysts believe this chip manufacturer could lead the pack, you will also discover four more potential winners for the coming year.

Click here to download your Free Research Report…

Sponsored

The findings of this study may clarify new clinical workflow strategies that will affect how many different forms of arrhythmia are ablate. Cleveland Clinic has been chosen by BioSig Technologies because it is a top medical facility with a reputation for quality, research capacity, and shared interest in utilizing digital signal processing technologies to develop cardiac electrophysiology.

Cleveland Clinic has a long history of innovation in the field of electrophysiology and cardiovascular disease as a non-profit center for research, teaching, and treatment. Their dedication to clinical research and making sure that patients have access to the best therapies with efficiency and efficacy is embodied by BSGM.

As it finds innovative methods to use digital signal processing technologies to positively improve procedural processes, BSGM will be collaborating with Cleveland Clinic’s expertise. At Cleveland Clinic’s Heart, Vascular & Thoracic Institute’s Main and Fairview campuses, the PURE EP System from BSGM is presently undergoing assessment.

In October, BSGM revealed that the PURE EP System had been purchased by San Antonio Methodist Hospital. The purchase, one of several in the works, confirms the ongoing growth of BSGM’s client base and footprint in the United States.

How will BSGM progress go forward?

In order to accelerate the PURE EP System’s nationwide commercial deployment, BioSig Technologies (BSGM) showed their technology to Methodist Hospital in San Antonio. The PURE EP System integrates with current processes to improve EP lab infrastructure, and it gives important signals of interest that are hidden in traditional systems, according to BSGM.

RELATED ARTICLES

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Recent Post